thanks everyone for your input - great time in PAB's history - we are all sleuthing anns and trying to work out what is going on. What we need to go on is: - outstanding 4th cohort preliminary results - everyone to take their RI's - Celgene to continue to dominate Amgen\Onyx in MM therapy Amgen\Onyx are moving swiftly on this imo - you don't buyout a company for $10b only to have a competitor have a superior or better marketed drug than yours. PAB could well be the answer for Amgen. They will not wait years before Phase 3'S IMO WHEN THEY CAN SPEED IT UP WITH THEIR OWN RESOURCES. I'm really excited about Xmas and the NY. GO PAB!
PAB Price at posting:
6.2¢ Sentiment: LT Buy Disclosure: Held
